HOW IT WORKS

Accumulation of indoxyl sulfate intensifies inflammatory responses, promotes degeneration of renal tubular epithelial cells and interstitial cells, this results in renal interstitial fibrosis and glomerulosclerosis, accelerating the decline of kidney function. 

​​​

ROCKS Kidney+ can reduce indoxyl sulfate, a protein bound uremic toxin. By lowering indoxyl sulfate levels, it helps reduce these risks and slow down the progression of renal impairment.

​

EFFICACY TEST AND REPORTS

Results of clinical trials on 3rd and 4th stage Chronic Kidney Diease (CKD) patients after a 12-week course:

​

• Reduced Blood Urea and Nitrogen (BUN) levels

• Reduced Uric Acid levels

• Lower Blood Sugar levels

• Lower Triglyceride levels

• Lower Indoxyl Sulfate (IS) levels
  in 40% of test subjects

​

This product has passed the Microbial Heavy Metal and Pesticide residue test. View certification, Product data sheet and Antibiotics susceptibility chart .

​

More information:

​

1. Journal of Food and Nutrional Research: The Effect of a Nutritional Supplement on Chronic Kidney Disease Patients. Vol. 4, No. 2, 2016, pp 115-120. ...Read more

​

2. Journal of Renal Nutrition: The Efficacy of Lactobacillus-Containing Probiotic Supplementation in Hemodialysis Patients: A Randomized, Double-Blind, Placebo-Controlled Trial. - This study was performed to determine the effects of probiotic supplementation on cholesterol-triglyceride ratio, an indirect marker of insulin resistance, protein-bound uremic toxins, biomarkers of inflammation, and microbial translocation in end-stage renal disease patients on hemodialysis... Read more

3. Patent application trials: To reduce the renal function of the injured kidney, to treat or/and prevent metabolic syndrome and its symptoms, to prevent hyperuricemia, to improve or/and prevent hypocalcemia, and to slow or avoid chronic kidney disease Symptoms of discomfort can reduce mortality, maintain a good quality of life, and delay the deterioration of kidney disease.

Read more ... [English] [Chinese]

​

4, Justia Patents; US Patent for Lactic acid bacteria and use thereof Patent (Patent # 10,238,696) - Lactic acid bacteria, which are isolated Lactococcus lactis subsp. lactis LL358 and isolated Lactobacillus salivarius LS159 respectively. By administering a composition comprising the lactic acid bacteria of the invention, renal injury, metabolic syndrome, hyperuricemia, hypocalcemia, and other disorders can be effectively ameliorated or treated...Read more